πŸš€ Accelerating Drug Discovery with Pharmidex In Silico Expertise, the complete Video! πŸ§¬πŸ”¬
March 3, 2025

At Pharmidex, we harness cutting-edge computational tools to fast-track drug discovery.


Our 5-Step In Silico Drug Discovery Process

πŸ”Ή 1. Target Structure Determination – High-resolution X-ray, Cryo-EM & homology modeling

πŸ”Ή 2. Ligand Identification – Virtual screening, de novo design & library mining

πŸ”Ή 3. Active/Binding Site Analysis – Molecular dynamics & protein flexibility studies

πŸ”Ή 4. Molecular Docking & Pharmacophore Modeling – Gold-standard binding affinity predictions

πŸ”Ή 5. Validation & Optimization – Target validation & pathway analysis


πŸ’‘ Need to discover a drug for your target?

πŸ’‘ Have drug candidates and need to identify their target?


With expert computational, structural, and molecular biology insights, we provide:

βœ… Advanced hit & binding site identification

βœ… 2D & 3D ligand-based design

βœ… Molecular dynamics & target validation


πŸ“© Let’s collaborate and drive innovation forward!


#Pharmidex #DrugDiscovery #InSilico #Biotech #AIinDrugDiscovery #PharmaInnovation

We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 30, 2025
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 28, 2025
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. πŸ‘©‍πŸ”¬ πŸ‘¨‍πŸ”¬ Welcome to the team, Gabrielle and Mohammed!
BATA Taste Aversion
July 24, 2025
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: βœ… Bitter-tasting APIs βœ… Unpalatable excipients βœ… The success of taste-masking strategies βœ… Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
More Posts